Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Phase of Trial: Phase III
Latest Information Update: 11 Mar 2019
Price : $35 *
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms Protocol-V
- 06 Mar 2019 Status changed from recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 01 Jun 2016 Planned End Date changed from 1 Mar 2017 to 1 Aug 2018.